{"id":"W4409504327","doi":"10.1038/s43018-025-00967-6","title":"Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial","year":2025,"lang":"en","type":"erratum","venue":"Nature Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; Clinical trial; Phases of clinical research; Lymphoma; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006254404,0.001609253,0.001858167,0.001852399,0.001744895,0.002914988,0.002931046,0.005173367,0.0213259],"category_scores_gemma":[0.0573407,0.0008496677,0.001472837,0.001655243,0.001482516,0.001342546,0.001028758,0.01146596,0.01506602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003397118,"about_ca_system_score_gemma":0.005115355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0072076,"about_ca_topic_score_gemma":0.008490966,"domain_scores_codex":[0.995702,0.000783012,0.0007717346,0.0007295983,0.001697,0.0003166631],"domain_scores_gemma":[0.975327,0.008701101,0.00119962,0.001104859,0.01243988,0.001227583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007127071,0.000008761521,0.00006477266,0.0001126123,0.00001976176,0.0002618676,0.00001740384,0.00004274631,0.0000411037,0.0003981068,0.9936787,0.00528285],"study_design_scores_gemma":[0.00029633,0.00007446507,0.0009714206,0.0007618985,0.0001901278,0.001936821,0.00008055665,0.0005959047,0.0009515993,0.002251054,0.9918206,0.00006922702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0002353155,0.001013921,0.0007661652,0.06312954,0.9318737,0.00003755076,0.0009430889,0.0002387317,0.001762048],"genre_scores_gemma":[0.0266753,0.0125084,0.007760135,0.2280155,0.5547824,0.0003804926,0.003432212,0.001748004,0.1646977],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0213259,"threshold_uncertainty_score":0.07134229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005353447077030111,"score_gpt":0.2809839314133019,"score_spread":0.2756304843362718,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}